West Tower Group’s Astera Labs ALAB Stock Holding History

West Tower Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-600	Closed	-$36.3K	–	143
2024 Q2	$36.3K	Buy	+600	New	+$41.6K	0.1%	92

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

West Tower Group's ALAB Position: Q3 2024 in Review

West Tower Group sold out of Astera Labs (ALAB) in Q3 2024, closing a stake of 600 shares — an estimated $36.3K sold.

West Tower Group first reported a position in ALAB in Q2 2024 and held it in 1 quarter. The position peaked at $36.3K in Q2 2024. 245 funds tracked by Wall St. Rank hold ALAB as of Q3 2024.

West Tower Group reported no remaining Astera Labs position as of Q3 2024 after selling out during the quarter.
West Tower Group sold 600 Astera Labs shares in Q3 2024, an estimated $36.3K.
West Tower Group first reported a position in Astera Labs in Q2 2024 and held it in 1 quarter.
West Tower Group's Astera Labs position peaked at $36.3K in Q2 2024.
245 funds tracked by Wall St. Rank held Astera Labs as of Q3 2024.

Based on West Tower Group's 13F filing for Q3 2024, filed 13 Nov 2024.